C. B. Allard Et Al. , "Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States," UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11, 2015
Allard, C. B. Et Al. 2015. Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11 .
Allard, C. B., Gelpi-Hammerschmidt, F., Harshman, L. C., Choueiri, T. K., Faiena, I., Modi, P., ... Chung, B. I.(2015). Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11.
Allard, Christopher Et Al. "Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States," UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11, 2015
Allard, Christopher B. Et Al. "Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States." UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11, 2015
Allard, C. B. Et Al. (2015) . "Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States." UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.33, no.11.
@article{article, author={Christopher B. Allard Et Al. }, title={Contemporary rends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States}, journal={UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS}, year=2015}